HER-2/<it>neu </it>amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection
<p>Abstract</p> <p>Background</p> <p>Accurate assessment of HER-2/<it>neu </it>status is crucial for proper prognostic information and to offer direct appropriate treatment for breast cancer patients. Next to immunohistochemistry (IHC) to evaluate HER2 prote...
Main Authors: | Ezendam Chantal, de Weger Roel A, Moelans Cathy B, van Diest Paul J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-01-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/4 |
Similar Items
-
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
by: Cathy B. Moelans, et al.
Published: (2009-01-01) -
Multiplex Ligation-Dependent Probe Amplification to Detect HER2 Amplification in Breast Cancer: New Insights in Optimal Cut-Off Value
by: Cathy B. Moelans, et al.
Published: (2010-01-01) -
Added value of HER-2 amplification testing by multiplex ligation-dependent probe amplification in invasive breast cancer.
by: Chantal C H J Kuijpers, et al.
Published: (2013-01-01) -
ESR1 Amplification is Rare in Breast Cancer and is Associated with High Grade and High Proliferation: A Multiplex Ligation-Dependent Probe Amplification Study
by: Cathy B. Moelans, et al.
Published: (2010-01-01) -
Molecular Differences between Ductal Carcinoma In Situ and Adjacent Invasive Breast Carcinoma: A Multiplex Ligation-Dependent Probe Amplification Study
by: Cathy B. Moelans, et al.
Published: (2010-01-01)